QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, February 16, 2005, 25(7):1620-1628; doi:10.1523/JNEUROSCI.4279-04.2005

This Article Full Text Full Text (PDF) Supplemental data Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (14) Citing Articles via Google Scholar Google Scholar Articles by Goodfellow, J. A. Articles by Willison, H. J. Search for Related Content PubMed PubMed Citation Articles by Goodfellow, J. A. Articles by Willison, H. J.

 Previous Article  |  Next Article 

Neurobiology of Disease
Overexpression of GD1a Ganglioside Sensitizes Motor Nerve Terminals to Anti-GD1a Antibody-Mediated Injury in a Model of Acute Motor Axonal Neuropathy

John A. Goodfellow,¹ Tyrone Bowes,^1,2 Kazim Sheikh,³ Masaaki Odaka,^1,4 Susan K. Halstead,¹ Peter D. Humphreys,¹ Eric R. Wagner,¹ Nobuhiro Yuki,⁴ Koichi Furukawa,⁵ Keiko Furukawa,⁵ Jaap J. Plomp,^6,7 and Hugh J. Willison¹

¹Division of Clinical Neurosciences, Institute of Neurological Sciences, Southern General Hospital, Glasgow G51 4TF, United Kingdom, ²Department of Biological Sciences, Glasgow Caledonian University, Glasgow G4 OBA, United Kingdom, ³Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, ⁴Department of Neurology, Dokkyo University School of Medicine, Tochigi 321-0293, Japan, ⁵Department of Biochemistry II, Nagoya University School of Medicine, Nagoya 466-0065, Japan, and Departments of ⁶Neurology and ⁷Neurophysiology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands

Anti-GD1a ganglioside antibodies (Abs) are the serological hallmark of the acute motor axonal form of the post-infectious paralysis, Guillain-Barré syndrome. Development of a disease model in mice has been impeded by the weak immunogenicity of gangliosides and the apparent resistance of GD1a-containing neural membranes to anti-GD1a antibody-mediated injury. Here we used mice with altered ganglioside biosynthesis to generate such a model at motor nerve terminals. First, we bypassed immunological tolerance by immunizing GD1a-deficient, -1,4-N-acetylgalactosaminyl transferase knock-out mice with GD1a ganglioside-mimicking antigens from Campylobacter jejuni and generated high-titer anti-GD1a antisera and complement fixing monoclonal Abs (mAbs). Next, we exposed ex vivo nerve-muscle preparations from GD1a-overexpressing, GD3 synthase knock-out mice to the anti-GD1a mAbs in the presence of a source of complement and investigated morphological and electrophysiological damage. Dense antibody and complement deposits were observed only over presynaptic motor axons, accompanied by severe ultrastructural damage and electrophysiological blockade of motor nerve terminal function. Perisynaptic Schwann cells and postsynaptic membranes were unaffected. In contrast, normal mice were not only unresponsive to immunization with GD1a but also resistant to neural injury during anti-GD1a Ab exposure, demonstrating the central role of membrane antigen density in modulating both immune tolerance to GD1a and axonal susceptibility to anti-GD1a Abmediated injury. Identical paralyzing effects were observed when testing mouse and human anti-GD1a-positive sera. These data indicate that anti-GD1a Abs arise via molecular mimicry and are likely to be clinically relevant in injuring peripheral nerve axonal membranes containing sufficiently high levels of GD1a.

Key words: neuromuscular; denervation; axon terminal; end plate; MEPP; ganglioside; glycosyltransferase; autoimmunity; neuropathy

---

Received Oct 14, 2004; revised December 23, 2004; accepted December 25, 2004.

This article has been cited by other articles:

				P. H. H. Lopez, G. Zhang, M. A. Bianchet, R. L. Schnaar, and K. A. Sheikh Structural requirements of anti-GD1a antibodies determine their target specificity Brain, July 1, 2008; 131(7): 1926 - 1939. [Abstract] [Full Text] [PDF]

				H. C. Lehmann and H.-P. Hartung Complementing the therapeutic armamentarium for Miller Fisher Syndrome and related immune neuropathies Brain, May 1, 2008; 131(5): 1168 - 1170. [Full Text] [PDF]

				K. Susuki, M. N. Rasband, K. Tohyama, K. Koibuchi, S. Okamoto, K. Funakoshi, K. Hirata, H. Baba, and N. Yuki Anti-GM1 Antibodies Cause Complement-Mediated Disruption of Sodium Channel Clusters in Peripheral Motor Nerve Fibers J. Neurosci., April 11, 2007; 27(15): 3956 - 3967. [Abstract] [Full Text] [PDF]

				H. C. Lehmann, P. H. H. Lopez, G. Zhang, T. Ngyuen, J. Zhang, B. C. Kieseier, S. Mori, and K. A. Sheikh Passive Immunization with Anti-Ganglioside Antibodies Directly Inhibits Axon Regeneration in an Animal Model J. Neurosci., January 3, 2007; 27(1): 27 - 34. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help